Kerry Casey is a seasoned translational discovery immunologist with over 12 years of experience in tracking innate and adaptive immune responses. Currently serving as the Director of Preclinical & Translational Research in Immunology & Inflammation at Regeneron, Kerry has previously held leadership positions at MedImmune and the Allen Institute for Immunology. With a strong track record in drug development, biomarker discovery, and precision medicine, Kerry has contributed to various clinical trials and has published influential research in the field. Kerry holds a Ph.D. in Microbiology, Immunology & Cancer Biology from the University of Minnesota and a B.S. in Medical Microbiology & Immunology from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices